Answering the Call in Nonadvanced Systemic Mastocytosis

Targeted Approaches to Patient Management

Staying Vigilant for Immunocompromised Patients

Hot Topics in Asthma

Increasing Control and Preventing Exacerbations

Clinical Consults in Severe Asthma

New Approaches to Targeted Therapy

Reducing Risks in Asthma

Mucus Plugs and Airway Obstruction

Top 10 COVID Queries

Answers to Your Questions About Managing High-Risk Patients

Clinical Consults in COPD

Updates to Best Practice Recommendations

What’s the Latest in Severe Asthma?

Making the Call in Nonadvanced Systemic Mastocytosis

Optimizing Multidisciplinary Management

Answering the Call in Severe Asthma

Expanding Roles for Biologic Treatment Regimens

Making the Rounds on Systemic Mastocytosis

Accelerating Diagnosis and Treatment

Strengthening Your COVID-19 Management Technique

Exercising Best Practices for Hospitalized Patients

New Horizons in Severe Asthma

From the Airway Epithelium to Improved Patient Outcomes

What’s New in the Management of COVID-19

Incorporating New Data and Updated Guidelines Into Daily Practice

Flexing Your Muscles in Familial Hypercholesterolemia

Best Practices for Screening, Diagnosis, and Management

Best Practices in COPD

Practical Updates on the 2023 GOLD Guidelines

What’s Next

Exploring New Treatment Avenues in Nonadvanced Systemic Mastocytosis

What’s the Latest on COVID-19?

A Call to Action

Monoclonal Antibodies for the Prevention and Treatment of COVID-19

Are You Up to Date on COVID-19 Diagnosis and Treatment Guidelines?

Test Your Mastery!

Clearing the Way in Atopic Dermatitis

A Case-Based Update on Pediatric Patients

Clinical Issues in Severe Asthma

Debates and Discussions About New Upstream Treatment Avenues

Catching Your Breath in COPD

Answering the Bell in Severe Asthma

New Pathways to Optimize Patient Outcomes

Monoclonal Antibodies for COVID-19

New Avenues to Pre-Exposure Prophylaxis

Monoclonal Antibodies for COVID-19

An Update on Best Practices

Is It Systemic Mastocytosis?

Best Practices for Diagnosis and Management

Clinical Updates in COVID-19

Recent Developments in Anti-SARS-CoV-2 Monoclonal Antibodies for Treatment

Targeting Clear Horizons

Finding the Path in Chronic Rhinosinusitis with Nasal Polyps

Putting a Spotlight on Systemic Mastocytosis

A Multidisciplinary Look at Early Diagnosis and Management

Getting Low in Familial Hypercholesterolemia

Reducing LDL-C and a Lifetime of Cardiovascular Risk

Answering the Call

Interdisciplinary Management of Eosinophilic Esophagitis and Hereditary Angioedema

Finding the Path in Eosinophilic Esophagitis

Interdisciplinary Strategies for Adult and Pediatric Patients

Getting Up To Speed In Moderate-To-Severe Asthma

Evolving Best Practices for Pediatric Patients

Cause for Alarm

New Avenues to the Management of Severe Asthma

Minimizing Patient Risks From COVID-19

An Update on Monoclonal Antibody Therapies

Clinical Issues in COVID-19

Debates and Discussions about Monoclonal Antibody Therapies

Comprehensive Management in COPD

A Whole Patient Case Series

COPD Cases & Conversations

Preventing COPD Exacerbations to Improve Outcomes

Where are We Now In Moderate-to-Severe Asthma?

From Comprehensive Patient Evaluations to Individualized Evidence-based Care

Swimming Upstream in Severe Asthma

New Pathways to Patient Management

A Breath of Fresh Air in Pediatric Asthma

Shared Decision-making in the Era of Biologics

Coming up for Air to Manage Patients With Severe Asthma

Updates on Chronic Rhinosinusitis with Nasal Polyps

Evolving Best Practices for Patient Management

Demystifying New Evidence for COPD Management

Best Practices for Primary Care

COPD Cases and Conversations

A Focus on Exacerbation Prevention

Finding the Right Path in Severe Asthma

Mechanistic Insights and Emerging Treatment Options

COPD in Managed Care

The Clinical and Utilization Benefits of Exacerbation Prevention

Airing It Out

A Case-Based Conversation on Managing Asthma and Chronic Rhinosinusitis With Nasal Polyposis